Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication
Zhengwei Wan(University of Electronic Science and Technology of China), Shixing Tang(Southern Medical University), Fengyu Hu(Guangzhou Eighth People's Hospital), Jingwei Shui(Southern Medical University), Yuanhao Liang(Jiangmen Central Hospital), Yuanping Zhou(Guangdong Medical College), Haiying Wang(Southern Medical University), Jun-Wei Liu(Nanfang Hospital), Xiaoping Tang(Guangzhou Eighth People's Hospital), Linghua Li(Guangzhou Eighth People's Hospital), Chengguang Hu(Nanfang Hospital), Weiping Cai(Guangzhou Eighth People's Hospital)
Cited by 15
Related Papers
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019
|BMJ Oncology|2023|275
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
|Immunity|2017|184
A global call for talaromycosis to be recognised as a neglected tropical disease
|The Lancet Global Health|2021|143